One of a few emerging companies invited to the European Biotech Conference: http://biz.yahoo.com/prnews/001006/biopartner.html Dnaprint (DNAP) is an emerging biotech company and is trading under $1 !!! 1) CEO (Dr. Tony Frudakis) Lead scientist for Corixa starts his own company a few months ago 2) Company is formed by a reverse merger of a pinksheet company 3) DNAP has already completed the accounting to get off the pinksheets and should be listed on the OTCBB soon. 4) Dr. Frudakis was responsible for a patent that sold for $54,000,000 to Smith Kline Beecham while he was at Corixa. 5) Corixa's stock has gone from 14 Cents a few years ago to 50 Dollars today. 6) According to the Barron's article (9/25/00 pg 52), Dnaprint is in the late stages of forming strategic alliances with major companies.